nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—MPO—superior mesenteric artery—pancreatic cancer	0.25	0.893	CbGeAlD
Cefdinir—MPO—pancreas—pancreatic cancer	0.00903	0.0322	CbGeAlD
Cefdinir—SLC15A1—digestive system—pancreatic cancer	0.00857	0.0306	CbGeAlD
Cefdinir—MPO—digestive system—pancreatic cancer	0.00771	0.0275	CbGeAlD
Cefdinir—SLC22A5—digestive system—pancreatic cancer	0.00466	0.0166	CbGeAlD
Cefdinir—Pneumonia—Docetaxel—pancreatic cancer	0.0012	0.00167	CcSEcCtD
Cefdinir—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.0012	0.00166	CcSEcCtD
Cefdinir—Loss of consciousness—Irinotecan—pancreatic cancer	0.00119	0.00165	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00118	0.00165	CcSEcCtD
Cefdinir—Dyspepsia—Sunitinib—pancreatic cancer	0.00118	0.00164	CcSEcCtD
Cefdinir—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.00118	0.00164	CcSEcCtD
Cefdinir—Leukopenia—Gemcitabine—pancreatic cancer	0.00118	0.00164	CcSEcCtD
Cefdinir—Renal failure—Docetaxel—pancreatic cancer	0.00117	0.00163	CcSEcCtD
Cefdinir—Myocardial infarction—Docetaxel—pancreatic cancer	0.00117	0.00163	CcSEcCtD
Cefdinir—Hypertension—Irinotecan—pancreatic cancer	0.00117	0.00162	CcSEcCtD
Cefdinir—Jaundice—Docetaxel—pancreatic cancer	0.00116	0.00162	CcSEcCtD
Cefdinir—Stomatitis—Docetaxel—pancreatic cancer	0.00116	0.00162	CcSEcCtD
Cefdinir—Hepatic failure—Epirubicin—pancreatic cancer	0.00116	0.00162	CcSEcCtD
Cefdinir—Decreased appetite—Sunitinib—pancreatic cancer	0.00116	0.00162	CcSEcCtD
Cefdinir—Conjunctivitis—Docetaxel—pancreatic cancer	0.00116	0.00161	CcSEcCtD
Cefdinir—Leukopenia—Fluorouracil—pancreatic cancer	0.00116	0.00161	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00116	0.0016	CcSEcCtD
Cefdinir—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00115	0.0016	CcSEcCtD
Cefdinir—Constipation—Sunitinib—pancreatic cancer	0.00114	0.00159	CcSEcCtD
Cefdinir—Hypertension—Gemcitabine—pancreatic cancer	0.00114	0.00158	CcSEcCtD
Cefdinir—Renal failure acute—Epirubicin—pancreatic cancer	0.00113	0.00157	CcSEcCtD
Cefdinir—Asthenia—Tamoxifen—pancreatic cancer	0.00112	0.00156	CcSEcCtD
Cefdinir—Convulsion—Fluorouracil—pancreatic cancer	0.00112	0.00156	CcSEcCtD
Cefdinir—Chest pain—Gemcitabine—pancreatic cancer	0.00112	0.00156	CcSEcCtD
Cefdinir—Agranulocytosis—Docetaxel—pancreatic cancer	0.00112	0.00155	CcSEcCtD
Cefdinir—Asthenia—Erlotinib—pancreatic cancer	0.00111	0.00154	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.00111	0.00154	CcSEcCtD
Cefdinir—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.00111	0.00154	CcSEcCtD
Cefdinir—Pruritus—Tamoxifen—pancreatic cancer	0.00111	0.00154	CcSEcCtD
Cefdinir—Anaphylactic shock—Irinotecan—pancreatic cancer	0.0011	0.00153	CcSEcCtD
Cefdinir—Chest pain—Fluorouracil—pancreatic cancer	0.0011	0.00153	CcSEcCtD
Cefdinir—Renal impairment—Epirubicin—pancreatic cancer	0.0011	0.00153	CcSEcCtD
Cefdinir—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00109	0.00152	CcSEcCtD
Cefdinir—Pruritus—Erlotinib—pancreatic cancer	0.00109	0.00152	CcSEcCtD
Cefdinir—Purpura—Epirubicin—pancreatic cancer	0.00109	0.00151	CcSEcCtD
Cefdinir—Shock—Irinotecan—pancreatic cancer	0.00108	0.00151	CcSEcCtD
Cefdinir—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00108	0.0015	CcSEcCtD
Cefdinir—Haemoglobin—Docetaxel—pancreatic cancer	0.00108	0.0015	CcSEcCtD
Cefdinir—Hepatic failure—Doxorubicin—pancreatic cancer	0.00108	0.0015	CcSEcCtD
Cefdinir—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00107	0.00149	CcSEcCtD
Cefdinir—Haemorrhage—Docetaxel—pancreatic cancer	0.00107	0.00149	CcSEcCtD
Cefdinir—Cardiac failure—Epirubicin—pancreatic cancer	0.00107	0.00149	CcSEcCtD
Cefdinir—Diarrhoea—Tamoxifen—pancreatic cancer	0.00107	0.00148	CcSEcCtD
Cefdinir—Abdominal pain—Sunitinib—pancreatic cancer	0.00106	0.00147	CcSEcCtD
Cefdinir—Body temperature increased—Sunitinib—pancreatic cancer	0.00106	0.00147	CcSEcCtD
Cefdinir—Diarrhoea—Erlotinib—pancreatic cancer	0.00106	0.00147	CcSEcCtD
Cefdinir—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00106	0.00147	CcSEcCtD
Cefdinir—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00105	0.00146	CcSEcCtD
Cefdinir—Anorexia—Irinotecan—pancreatic cancer	0.00105	0.00146	CcSEcCtD
Cefdinir—Renal failure acute—Doxorubicin—pancreatic cancer	0.00105	0.00146	CcSEcCtD
Cefdinir—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00103	0.00144	CcSEcCtD
Cefdinir—Dizziness—Tamoxifen—pancreatic cancer	0.00103	0.00144	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.00103	0.00142	CcSEcCtD
Cefdinir—Anorexia—Gemcitabine—pancreatic cancer	0.00102	0.00142	CcSEcCtD
Cefdinir—Dizziness—Erlotinib—pancreatic cancer	0.00102	0.00142	CcSEcCtD
Cefdinir—Renal impairment—Doxorubicin—pancreatic cancer	0.00102	0.00141	CcSEcCtD
Cefdinir—Erythema multiforme—Docetaxel—pancreatic cancer	0.00101	0.00141	CcSEcCtD
Cefdinir—Anorexia—Fluorouracil—pancreatic cancer	0.00101	0.0014	CcSEcCtD
Cefdinir—Purpura—Doxorubicin—pancreatic cancer	0.001	0.00139	CcSEcCtD
Cefdinir—Insomnia—Irinotecan—pancreatic cancer	0.000997	0.00138	CcSEcCtD
Cefdinir—Vomiting—Tamoxifen—pancreatic cancer	0.000993	0.00138	CcSEcCtD
Cefdinir—Cardiac failure—Doxorubicin—pancreatic cancer	0.000992	0.00138	CcSEcCtD
Cefdinir—Hypersensitivity—Sunitinib—pancreatic cancer	0.000986	0.00137	CcSEcCtD
Cefdinir—Rash—Tamoxifen—pancreatic cancer	0.000985	0.00137	CcSEcCtD
Cefdinir—Dermatitis—Tamoxifen—pancreatic cancer	0.000984	0.00137	CcSEcCtD
Cefdinir—Vomiting—Erlotinib—pancreatic cancer	0.000983	0.00137	CcSEcCtD
Cefdinir—Somnolence—Irinotecan—pancreatic cancer	0.00098	0.00136	CcSEcCtD
Cefdinir—Headache—Tamoxifen—pancreatic cancer	0.000979	0.00136	CcSEcCtD
Cefdinir—Rash—Erlotinib—pancreatic cancer	0.000975	0.00135	CcSEcCtD
Cefdinir—Dermatitis—Erlotinib—pancreatic cancer	0.000974	0.00135	CcSEcCtD
Cefdinir—Insomnia—Gemcitabine—pancreatic cancer	0.000971	0.00135	CcSEcCtD
Cefdinir—Dyspepsia—Irinotecan—pancreatic cancer	0.00097	0.00135	CcSEcCtD
Cefdinir—Headache—Erlotinib—pancreatic cancer	0.000968	0.00135	CcSEcCtD
Cefdinir—Asthenia—Sunitinib—pancreatic cancer	0.00096	0.00133	CcSEcCtD
Cefdinir—Decreased appetite—Irinotecan—pancreatic cancer	0.000958	0.00133	CcSEcCtD
Cefdinir—Insomnia—Fluorouracil—pancreatic cancer	0.000955	0.00133	CcSEcCtD
Cefdinir—Somnolence—Gemcitabine—pancreatic cancer	0.000955	0.00133	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000952	0.00132	CcSEcCtD
Cefdinir—Pruritus—Sunitinib—pancreatic cancer	0.000947	0.00132	CcSEcCtD
Cefdinir—Constipation—Irinotecan—pancreatic cancer	0.000943	0.00131	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000942	0.00131	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000942	0.00131	CcSEcCtD
Cefdinir—Somnolence—Fluorouracil—pancreatic cancer	0.000939	0.0013	CcSEcCtD
Cefdinir—Decreased appetite—Gemcitabine—pancreatic cancer	0.000933	0.0013	CcSEcCtD
Cefdinir—Dyspepsia—Fluorouracil—pancreatic cancer	0.000929	0.00129	CcSEcCtD
Cefdinir—Nausea—Tamoxifen—pancreatic cancer	0.000928	0.00129	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000927	0.00129	CcSEcCtD
Cefdinir—Constipation—Gemcitabine—pancreatic cancer	0.000918	0.00128	CcSEcCtD
Cefdinir—Nausea—Erlotinib—pancreatic cancer	0.000918	0.00128	CcSEcCtD
Cefdinir—Decreased appetite—Fluorouracil—pancreatic cancer	0.000918	0.00127	CcSEcCtD
Cefdinir—Diarrhoea—Sunitinib—pancreatic cancer	0.000916	0.00127	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000912	0.00127	CcSEcCtD
Cefdinir—Asthma—Epirubicin—pancreatic cancer	0.000904	0.00126	CcSEcCtD
Cefdinir—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000901	0.00125	CcSEcCtD
Cefdinir—Dizziness—Sunitinib—pancreatic cancer	0.000885	0.00123	CcSEcCtD
Cefdinir—Abdominal pain—Irinotecan—pancreatic cancer	0.000871	0.00121	CcSEcCtD
Cefdinir—Body temperature increased—Irinotecan—pancreatic cancer	0.000871	0.00121	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000871	0.00121	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000871	0.00121	CcSEcCtD
Cefdinir—Pancytopenia—Epirubicin—pancreatic cancer	0.000858	0.00119	CcSEcCtD
Cefdinir—Vomiting—Sunitinib—pancreatic cancer	0.000851	0.00118	CcSEcCtD
Cefdinir—Body temperature increased—Gemcitabine—pancreatic cancer	0.000849	0.00118	CcSEcCtD
Cefdinir—Neutropenia—Epirubicin—pancreatic cancer	0.000845	0.00117	CcSEcCtD
Cefdinir—Rash—Sunitinib—pancreatic cancer	0.000844	0.00117	CcSEcCtD
Cefdinir—Dermatitis—Sunitinib—pancreatic cancer	0.000843	0.00117	CcSEcCtD
Cefdinir—Headache—Sunitinib—pancreatic cancer	0.000838	0.00116	CcSEcCtD
Cefdinir—Asthma—Doxorubicin—pancreatic cancer	0.000836	0.00116	CcSEcCtD
Cefdinir—Leukopenia—Docetaxel—pancreatic cancer	0.000836	0.00116	CcSEcCtD
Cefdinir—Body temperature increased—Fluorouracil—pancreatic cancer	0.000835	0.00116	CcSEcCtD
Cefdinir—Loss of consciousness—Docetaxel—pancreatic cancer	0.000821	0.00114	CcSEcCtD
Cefdinir—Hypersensitivity—Irinotecan—pancreatic cancer	0.000812	0.00113	CcSEcCtD
Cefdinir—Pneumonia—Epirubicin—pancreatic cancer	0.000811	0.00113	CcSEcCtD
Cefdinir—Convulsion—Docetaxel—pancreatic cancer	0.000809	0.00112	CcSEcCtD
Cefdinir—Hypertension—Docetaxel—pancreatic cancer	0.000806	0.00112	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000799	0.00111	CcSEcCtD
Cefdinir—Chest pain—Docetaxel—pancreatic cancer	0.000795	0.0011	CcSEcCtD
Cefdinir—Nausea—Sunitinib—pancreatic cancer	0.000795	0.0011	CcSEcCtD
Cefdinir—Pancytopenia—Doxorubicin—pancreatic cancer	0.000794	0.0011	CcSEcCtD
Cefdinir—Renal failure—Epirubicin—pancreatic cancer	0.000792	0.0011	CcSEcCtD
Cefdinir—Asthenia—Irinotecan—pancreatic cancer	0.000791	0.0011	CcSEcCtD
Cefdinir—Jaundice—Epirubicin—pancreatic cancer	0.000786	0.00109	CcSEcCtD
Cefdinir—Stomatitis—Epirubicin—pancreatic cancer	0.000786	0.00109	CcSEcCtD
Cefdinir—Conjunctivitis—Epirubicin—pancreatic cancer	0.000783	0.00109	CcSEcCtD
Cefdinir—Neutropenia—Doxorubicin—pancreatic cancer	0.000782	0.00109	CcSEcCtD
Cefdinir—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000778	0.00108	CcSEcCtD
Cefdinir—Dry mouth—Docetaxel—pancreatic cancer	0.000777	0.00108	CcSEcCtD
Cefdinir—Asthenia—Gemcitabine—pancreatic cancer	0.00077	0.00107	CcSEcCtD
Cefdinir—Haematuria—Epirubicin—pancreatic cancer	0.000768	0.00107	CcSEcCtD
Cefdinir—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000762	0.00106	CcSEcCtD
Cefdinir—Pruritus—Gemcitabine—pancreatic cancer	0.00076	0.00106	CcSEcCtD
Cefdinir—Diarrhoea—Irinotecan—pancreatic cancer	0.000754	0.00105	CcSEcCtD
Cefdinir—Agranulocytosis—Epirubicin—pancreatic cancer	0.000752	0.00104	CcSEcCtD
Cefdinir—Pneumonia—Doxorubicin—pancreatic cancer	0.00075	0.00104	CcSEcCtD
Cefdinir—Shock—Docetaxel—pancreatic cancer	0.00075	0.00104	CcSEcCtD
Cefdinir—Pruritus—Fluorouracil—pancreatic cancer	0.000747	0.00104	CcSEcCtD
Cefdinir—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000746	0.00104	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000739	0.00103	CcSEcCtD
Cefdinir—Diarrhoea—Gemcitabine—pancreatic cancer	0.000735	0.00102	CcSEcCtD
Cefdinir—Renal failure—Doxorubicin—pancreatic cancer	0.000733	0.00102	CcSEcCtD
Cefdinir—Dizziness—Irinotecan—pancreatic cancer	0.000729	0.00101	CcSEcCtD
Cefdinir—Haemoglobin—Epirubicin—pancreatic cancer	0.000727	0.00101	CcSEcCtD
Cefdinir—Stomatitis—Doxorubicin—pancreatic cancer	0.000727	0.00101	CcSEcCtD
Cefdinir—Jaundice—Doxorubicin—pancreatic cancer	0.000727	0.00101	CcSEcCtD
Cefdinir—Anorexia—Docetaxel—pancreatic cancer	0.000726	0.00101	CcSEcCtD
Cefdinir—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000725	0.00101	CcSEcCtD
Cefdinir—Haemorrhage—Epirubicin—pancreatic cancer	0.000723	0.001	CcSEcCtD
Cefdinir—Diarrhoea—Fluorouracil—pancreatic cancer	0.000722	0.001	CcSEcCtD
Cefdinir—Haematuria—Doxorubicin—pancreatic cancer	0.000711	0.000988	CcSEcCtD
Cefdinir—Vomiting—Irinotecan—pancreatic cancer	0.000701	0.000974	CcSEcCtD
Cefdinir—Dizziness—Fluorouracil—pancreatic cancer	0.000698	0.00097	CcSEcCtD
Cefdinir—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000696	0.000967	CcSEcCtD
Cefdinir—Rash—Irinotecan—pancreatic cancer	0.000695	0.000965	CcSEcCtD
Cefdinir—Dermatitis—Irinotecan—pancreatic cancer	0.000694	0.000965	CcSEcCtD
Cefdinir—Headache—Irinotecan—pancreatic cancer	0.000691	0.000959	CcSEcCtD
Cefdinir—Insomnia—Docetaxel—pancreatic cancer	0.000689	0.000957	CcSEcCtD
Cefdinir—Erythema multiforme—Epirubicin—pancreatic cancer	0.000684	0.00095	CcSEcCtD
Cefdinir—Vomiting—Gemcitabine—pancreatic cancer	0.000683	0.000948	CcSEcCtD
Cefdinir—Somnolence—Docetaxel—pancreatic cancer	0.000677	0.000941	CcSEcCtD
Cefdinir—Rash—Gemcitabine—pancreatic cancer	0.000677	0.00094	CcSEcCtD
Cefdinir—Dermatitis—Gemcitabine—pancreatic cancer	0.000676	0.00094	CcSEcCtD
Cefdinir—Haemoglobin—Doxorubicin—pancreatic cancer	0.000673	0.000935	CcSEcCtD
Cefdinir—Headache—Gemcitabine—pancreatic cancer	0.000673	0.000934	CcSEcCtD
Cefdinir—Vomiting—Fluorouracil—pancreatic cancer	0.000671	0.000932	CcSEcCtD
Cefdinir—Dyspepsia—Docetaxel—pancreatic cancer	0.000671	0.000932	CcSEcCtD
Cefdinir—Haemorrhage—Doxorubicin—pancreatic cancer	0.000669	0.00093	CcSEcCtD
Cefdinir—Rash—Fluorouracil—pancreatic cancer	0.000666	0.000925	CcSEcCtD
Cefdinir—Dermatitis—Fluorouracil—pancreatic cancer	0.000665	0.000924	CcSEcCtD
Cefdinir—Decreased appetite—Docetaxel—pancreatic cancer	0.000662	0.00092	CcSEcCtD
Cefdinir—Headache—Fluorouracil—pancreatic cancer	0.000661	0.000919	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000658	0.000914	CcSEcCtD
Cefdinir—Nausea—Irinotecan—pancreatic cancer	0.000655	0.000909	CcSEcCtD
Cefdinir—Constipation—Docetaxel—pancreatic cancer	0.000652	0.000905	CcSEcCtD
Cefdinir—Nausea—Gemcitabine—pancreatic cancer	0.000638	0.000886	CcSEcCtD
Cefdinir—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000633	0.000879	CcSEcCtD
Cefdinir—Nausea—Fluorouracil—pancreatic cancer	0.000627	0.000871	CcSEcCtD
Cefdinir—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000623	0.000866	CcSEcCtD
Cefdinir—Flatulence—Epirubicin—pancreatic cancer	0.000621	0.000862	CcSEcCtD
Cefdinir—Abdominal pain—Docetaxel—pancreatic cancer	0.000602	0.000837	CcSEcCtD
Cefdinir—Body temperature increased—Docetaxel—pancreatic cancer	0.000602	0.000837	CcSEcCtD
Cefdinir—Agitation—Epirubicin—pancreatic cancer	0.000579	0.000804	CcSEcCtD
Cefdinir—Flatulence—Doxorubicin—pancreatic cancer	0.000574	0.000798	CcSEcCtD
Cefdinir—Leukopenia—Epirubicin—pancreatic cancer	0.000564	0.000783	CcSEcCtD
Cefdinir—Hypersensitivity—Docetaxel—pancreatic cancer	0.000561	0.00078	CcSEcCtD
Cefdinir—Loss of consciousness—Epirubicin—pancreatic cancer	0.000554	0.000769	CcSEcCtD
Cefdinir—Asthenia—Docetaxel—pancreatic cancer	0.000547	0.000759	CcSEcCtD
Cefdinir—Convulsion—Epirubicin—pancreatic cancer	0.000546	0.000758	CcSEcCtD
Cefdinir—Hypertension—Epirubicin—pancreatic cancer	0.000544	0.000755	CcSEcCtD
Cefdinir—Pruritus—Docetaxel—pancreatic cancer	0.000539	0.000749	CcSEcCtD
Cefdinir—Chest pain—Epirubicin—pancreatic cancer	0.000536	0.000745	CcSEcCtD
Cefdinir—Agitation—Doxorubicin—pancreatic cancer	0.000536	0.000744	CcSEcCtD
Cefdinir—Dry mouth—Epirubicin—pancreatic cancer	0.000524	0.000728	CcSEcCtD
Cefdinir—Leukopenia—Doxorubicin—pancreatic cancer	0.000522	0.000725	CcSEcCtD
Cefdinir—Diarrhoea—Docetaxel—pancreatic cancer	0.000521	0.000724	CcSEcCtD
Cefdinir—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000514	0.000714	CcSEcCtD
Cefdinir—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000512	0.000711	CcSEcCtD
Cefdinir—Shock—Epirubicin—pancreatic cancer	0.000506	0.000702	CcSEcCtD
Cefdinir—Convulsion—Doxorubicin—pancreatic cancer	0.000505	0.000701	CcSEcCtD
Cefdinir—Dizziness—Docetaxel—pancreatic cancer	0.000504	0.0007	CcSEcCtD
Cefdinir—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000503	0.000699	CcSEcCtD
Cefdinir—Hypertension—Doxorubicin—pancreatic cancer	0.000503	0.000699	CcSEcCtD
Cefdinir—Chest pain—Doxorubicin—pancreatic cancer	0.000496	0.000689	CcSEcCtD
Cefdinir—Anorexia—Epirubicin—pancreatic cancer	0.00049	0.000681	CcSEcCtD
Cefdinir—Dry mouth—Doxorubicin—pancreatic cancer	0.000485	0.000674	CcSEcCtD
Cefdinir—Vomiting—Docetaxel—pancreatic cancer	0.000485	0.000673	CcSEcCtD
Cefdinir—Rash—Docetaxel—pancreatic cancer	0.00048	0.000667	CcSEcCtD
Cefdinir—Dermatitis—Docetaxel—pancreatic cancer	0.00048	0.000667	CcSEcCtD
Cefdinir—Headache—Docetaxel—pancreatic cancer	0.000477	0.000663	CcSEcCtD
Cefdinir—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000476	0.000661	CcSEcCtD
Cefdinir—Shock—Doxorubicin—pancreatic cancer	0.000468	0.00065	CcSEcCtD
Cefdinir—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000466	0.000647	CcSEcCtD
Cefdinir—Insomnia—Epirubicin—pancreatic cancer	0.000465	0.000646	CcSEcCtD
Cefdinir—Somnolence—Epirubicin—pancreatic cancer	0.000457	0.000635	CcSEcCtD
Cefdinir—Anorexia—Doxorubicin—pancreatic cancer	0.000453	0.00063	CcSEcCtD
Cefdinir—Nausea—Docetaxel—pancreatic cancer	0.000453	0.000629	CcSEcCtD
Cefdinir—Dyspepsia—Epirubicin—pancreatic cancer	0.000452	0.000628	CcSEcCtD
Cefdinir—Decreased appetite—Epirubicin—pancreatic cancer	0.000447	0.000621	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000444	0.000616	CcSEcCtD
Cefdinir—Constipation—Epirubicin—pancreatic cancer	0.00044	0.000611	CcSEcCtD
Cefdinir—Insomnia—Doxorubicin—pancreatic cancer	0.00043	0.000597	CcSEcCtD
Cefdinir—Somnolence—Doxorubicin—pancreatic cancer	0.000423	0.000587	CcSEcCtD
Cefdinir—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00042	0.000584	CcSEcCtD
Cefdinir—Dyspepsia—Doxorubicin—pancreatic cancer	0.000419	0.000581	CcSEcCtD
Cefdinir—Decreased appetite—Doxorubicin—pancreatic cancer	0.000413	0.000574	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000411	0.00057	CcSEcCtD
Cefdinir—Constipation—Doxorubicin—pancreatic cancer	0.000407	0.000565	CcSEcCtD
Cefdinir—Body temperature increased—Epirubicin—pancreatic cancer	0.000406	0.000564	CcSEcCtD
Cefdinir—Abdominal pain—Epirubicin—pancreatic cancer	0.000406	0.000564	CcSEcCtD
Cefdinir—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000389	0.00054	CcSEcCtD
Cefdinir—Hypersensitivity—Epirubicin—pancreatic cancer	0.000379	0.000526	CcSEcCtD
Cefdinir—Abdominal pain—Doxorubicin—pancreatic cancer	0.000376	0.000522	CcSEcCtD
Cefdinir—Body temperature increased—Doxorubicin—pancreatic cancer	0.000376	0.000522	CcSEcCtD
Cefdinir—Asthenia—Epirubicin—pancreatic cancer	0.000369	0.000512	CcSEcCtD
Cefdinir—Pruritus—Epirubicin—pancreatic cancer	0.000364	0.000505	CcSEcCtD
Cefdinir—Diarrhoea—Epirubicin—pancreatic cancer	0.000352	0.000488	CcSEcCtD
Cefdinir—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00035	0.000487	CcSEcCtD
Cefdinir—Asthenia—Doxorubicin—pancreatic cancer	0.000341	0.000474	CcSEcCtD
Cefdinir—Dizziness—Epirubicin—pancreatic cancer	0.00034	0.000472	CcSEcCtD
Cefdinir—Pruritus—Doxorubicin—pancreatic cancer	0.000336	0.000467	CcSEcCtD
Cefdinir—Vomiting—Epirubicin—pancreatic cancer	0.000327	0.000454	CcSEcCtD
Cefdinir—Diarrhoea—Doxorubicin—pancreatic cancer	0.000325	0.000452	CcSEcCtD
Cefdinir—Rash—Epirubicin—pancreatic cancer	0.000324	0.00045	CcSEcCtD
Cefdinir—Dermatitis—Epirubicin—pancreatic cancer	0.000324	0.00045	CcSEcCtD
Cefdinir—Headache—Epirubicin—pancreatic cancer	0.000322	0.000447	CcSEcCtD
Cefdinir—Dizziness—Doxorubicin—pancreatic cancer	0.000315	0.000437	CcSEcCtD
Cefdinir—Nausea—Epirubicin—pancreatic cancer	0.000305	0.000424	CcSEcCtD
Cefdinir—Vomiting—Doxorubicin—pancreatic cancer	0.000302	0.00042	CcSEcCtD
Cefdinir—Rash—Doxorubicin—pancreatic cancer	0.0003	0.000417	CcSEcCtD
Cefdinir—Dermatitis—Doxorubicin—pancreatic cancer	0.0003	0.000416	CcSEcCtD
Cefdinir—Headache—Doxorubicin—pancreatic cancer	0.000298	0.000414	CcSEcCtD
Cefdinir—Nausea—Doxorubicin—pancreatic cancer	0.000282	0.000392	CcSEcCtD
